Metabolic and epigenetic reprogramming in the inflamed endothelium
发炎内皮的代谢和表观遗传重编程
基本信息
- 批准号:10793759
- 负责人:
- 金额:$ 26.17万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-02-01 至 2026-01-31
- 项目状态:未结题
- 来源:
- 关键词:Acetyl Coenzyme AAcuteAffectBloodCell physiologyCellsDiseaseEndothelial CellsEndotheliumEpigenetic ProcessFunctional disorderGlycolysisHigh-Throughput Nucleotide SequencingHistone AcetylationHumanInflammationInflammatoryLeadLocationMediatingMemoryMetabolicMetabolic PathwayMetabolismModificationMolecularNatural ImmunityOklahomaPhysiologicalPlayResearchRoleStimulusTestingTissuescell typeendothelial dysfunctionhistone modificationhuman diseasein vitro Assayin vivoinhibitorinsightmetabolic phenotypetherapeutic targettranscriptomicsvascular bed
项目摘要
Endothelial cells (ECs) form a dynamic interface between the blood and underlying tissue. Consistent with
their specialized functions across vascular beds and the ability to rapidly respond to different
(patho)physiological stimuli, ECs are both remarkably heterogeneous and highly metabolically active.
Furthermore, given its strategic location the endothelium plays a key role in inflammation, which underlies
many human diseases. Recent studies have shown that inflammation-induced EC dysfunction coincides with
changes in metabolic pathways, particularly enhanced glycolysis. As a result, cells can accumulate metabolic
intermediates such as acetyl-CoA. In addition to their known roles in metabolism, these metabolites are also
important in mediating epigenetic processes such as histone acetylation, and thereby regulate cell function.
While histone modifications are in principle reversible, they can be retained and lead to cellular memory. This
is not only important for cell type identity, but also plays a role in innate immunity. However, whether
inflammation-induced metabolic reprogramming in ECs can directly affect epigenetic modifications and cell
function, and/or lead to cellular memory, is not known. Therefore, this project proposes two specific aims to
test the hypothesis that inflammation-induced endothelial cell dysfunction is mediated by increased glycolysis
and histone acetylation, which can subsequently lead to a sustained epigenetic signature. Aim 1 will evaluate
the in vivo effects of acute inflammation on cellular function in an EC-specific manner using various metabolic
phenotyping and high-throughput sequencing approaches, both in the absence and presence of a glycolysis
inhibitor. In addition, targeted spatial transcriptomics will be employed to determine the contribution of distinct
EC subsets in inflammation-induced endothelial dysfunction. In aim 2 we will perform in vitro assays using
human ECs to further study the molecular mechanisms underlying metabolic reprogramming and epigenetic
modifications under inflammatory conditions, and determine whether these modifications can be retained and
lead to cell memory. The results obtained in this project will provide valuable insights into EC (dys)function,
and have the potential to identify therapeutic targets for metabolism- and/or epigenetic-centric treatment of
inflammation-related disorders.
内皮细胞(EC)在血液和下层组织之间形成动态界面。与
它们在血管床上的专业功能以及快速响应不同的能力
(病原)生理刺激,EC是明显的异质性和高度代谢活跃的。
此外,鉴于其战略位置,内皮在炎症中起关键作用,这是
许多人类疾病。最近的研究表明,炎症诱导的EC功能障碍与
代谢途径的变化,特别是增强的糖酵解。结果,细胞可以积累代谢
中间体,例如乙酰辅酶A。除了它们在代谢中的已知作用外,这些代谢也是
对于介导的表观遗传过程,例如组蛋白乙酰化以及调节细胞功能很重要。
尽管组蛋白的修饰原则上是可逆的,但可以保留并导致细胞记忆。这
不仅对细胞类型的身份很重要,而且在先天免疫中起作用。但是,是否
ECS中炎症诱导的代谢重编程可以直接影响表观遗传修饰和细胞
功能和/或导致蜂窝记忆尚不清楚。因此,该项目提出了两个具体目标
检验炎症诱导的内皮细胞功能障碍的假设是通过糖酵解增加介导的
和组蛋白乙酰化,随后会导致持续的表观遗传学特征。 AIM 1将评估
急性炎症对细胞功能的体内影响以EC特异性的方式使用各种代谢
在不存在和存在糖酵解的情况下,表型和高通量测序方法
抑制剂。此外,将采用有针对性的空间转录组学来确定不同的贡献
炎症引起的内皮功能障碍的EC集。在AIM 2中,我们将使用
人类EC进一步研究代谢重编程和表观遗传学的分子机制
在炎症条件下进行修改,并确定是否可以保留这些修改,并且
导致细胞内存。该项目中获得的结果将为EC(DYS)功能提供宝贵的见解,
并有可能确定代谢和/或以表观遗传治疗的治疗靶标的
与炎症有关的疾病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Audrey Cleuren其他文献
Audrey Cleuren的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Audrey Cleuren', 18)}}的其他基金
Contribution of Endothelial Changes and Increased Cardiovascular Risk to Alzheimer's Disease Pathogenesis
内皮变化和心血管风险增加对阿尔茨海默病发病机制的贡献
- 批准号:
10540499 - 财政年份:2021
- 资助金额:
$ 26.17万 - 项目类别:
Contribution of Endothelial Changes and Increased Cardiovascular Risk to Alzheimer's Disease Pathogenesis
内皮变化和心血管风险增加对阿尔茨海默病发病机制的贡献
- 批准号:
10302662 - 财政年份:2021
- 资助金额:
$ 26.17万 - 项目类别:
Contribution of Endothelial Changes and Increased Cardiovascular Risk to Alzheimer's Disease Pathogenesis
内皮变化和心血管风险增加对阿尔茨海默病发病机制的贡献
- 批准号:
10471427 - 财政年份:2021
- 资助金额:
$ 26.17万 - 项目类别:
相似国自然基金
SGO2/MAD2互作调控肝祖细胞的细胞周期再进入影响急性肝衰竭肝再生的机制研究
- 批准号:82300697
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
SSRP1/Sp-1转录调控的MFGE8通过SIRT6影响铁死亡在脓毒症急性肾损伤中的机制研究
- 批准号:82302418
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
人群mtDNA空间异质性对急性高原反应发病的影响机制研究
- 批准号:42377466
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
蜗牛粘液糖胺聚糖影响中性粒细胞粘附和迁移在治疗急性呼吸窘迫综合征中的作用研究
- 批准号:82360025
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
高甘油三酯通过TLR4/caspase-8影响急性胰腺炎CD4+T细胞程序性死亡的机制研究
- 批准号:82360135
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
相似海外基金
Acetyl CoA Carboxylase in the Metabolic Control of Inflammation
乙酰辅酶A羧化酶在炎症代谢控制中的作用
- 批准号:
10660439 - 财政年份:2023
- 资助金额:
$ 26.17万 - 项目类别:
Spatial Acetyl-CoA metabolism as a regulator of Hallmarks of Aging
空间乙酰辅酶A代谢作为衰老标志的调节剂
- 批准号:
10901039 - 财政年份:2023
- 资助金额:
$ 26.17万 - 项目类别:
Epigenetic-metabolic aspects of alcohol use disorder and early developmental alcohol exposure
酒精使用障碍和早期发育酒精暴露的表观遗传代谢方面
- 批准号:
10745787 - 财政年份:2023
- 资助金额:
$ 26.17万 - 项目类别:
AKR1a1 as a novel therapeutic target for Non-Alcoholic Fatty Liver Disease
AKR1a1作为非酒精性脂肪肝的新治疗靶点
- 批准号:
10385931 - 财政年份:2022
- 资助金额:
$ 26.17万 - 项目类别:
The effects of alcohol metabolism on hepatic and cardiac energy state and function
酒精代谢对肝脏和心脏能量状态和功能的影响
- 批准号:
10506788 - 财政年份:2022
- 资助金额:
$ 26.17万 - 项目类别: